Answers are grounded in this paper and cite their sources.
Is monitoring initial response to treatment always helpful in clinical management of patients? Bell and colleagues have developed a framework for deciding whether surrogate outcomes should be used to monitor initial response to treatment in chronic disease.
No takes yet. Share an insight, caveat, or question.
Bell et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: